Aster DM Healthcare Q4 FY26 Revenue up 18% to ₹1,182 Cr; Op. EBITDA up 31%

Aster DM Healthcare reported robust Q4 FY26 standalone financial results, with revenue growing 18% year-on-year to ₹1,182 Cr. Operating EBITDA (excluding Kasaragod) increased by 31% YoY to ₹253 Cr, and normalised PAT (excluding Kasaragod) rose 45% YoY to ₹153 Cr. The merger with Quality Care India Ltd (QCIL) received overwhelming shareholder approval (96.68% in favor) and is on track for completion in Q1 FY2026-27. On a combined proforma basis, Q4 FY26 revenue grew 18% to ₹2,361 Cr, with operating EBITDA up 25% to ₹517 Cr. The combined entity aims to exceed 15,500 beds, positioning it as a top three healthcare provider in India. Performance was driven by strong patient volumes and margin expansion across core hospital, clinics, and labs businesses.